Status:
RECRUITING
Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake
Lead Sponsor:
Cairo University
Conditions:
Fatty Liver, Nonalcoholic
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Detailed Description
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg...
Eligibility Criteria
Inclusion
- fatty liver (non alcoholic form)
- both sexes included
- obese subjects (class I)
Exclusion
- cardiac insult
- respiratory insult
- renal insult
- lower limb insult
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06596109
Start Date
September 10 2024
End Date
February 15 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of physical therapy Cairo university
Dokki, Giza Governorate, Egypt